Page 126 - 《中国药房》2025年3期

potential[J]. J Control Release，2022，348：186-205. 4901-4911.
[21] FITAIHI R，ABUKHAMEES S，CHUNG S H，et al. Opti‐ [34] CAMPOCHIARO P A，AVERY R，BROWN D M，et al.
mization of stereolithography 3D printing of microneedle Gene therapy for neovascular age-related macular degene-
micro-molds for ocular drug delivery[J]. Int J Pharm， ration by subretinal delivery of RGX-314：a phase 1/2a
2024，658：124195. dose-escalation study[J]. Lancet，2024，403（10436）：1563-
[22] MATADH A V，JAKKA D，PRAGATHI S G，et al. 1573.
Polymer-coated polymeric microneedles for intravitreal [35] JUNG J H，KIM S S，CHUNG H，et al. Six-month sus‐
delivery of dexamethasone[J]. Exp Eye Res，2023，231： tained delivery of anti-VEGF from in situ forming hydro‐
109467. gel in the suprachoroidal space[J]. J Control Release，
[23] JAKKA D，MATADH A V，SHANKAR V K，et al. 2022，352：472-484.
Polymer-coated polymeric （PCP） microneedles for con‐ [36] KANSARA V S，MUYA L W，CIULLA T A. Evaluation
trolled delivery of drugs：dermal and intravitreal[J]. J of long-lasting potential of suprachoroidal axitinib suspen‐
Pharm Sci，2022，111（10）：2867-2878. sion via ocular and systemic disposition in rabbits[J].
[24] BHATNAGAR S，SAJU A，CHEERLA K D，et al. Cor‐ Transl Vis Sci Technol，2021，10（7）：19.
neal delivery of besifloxacin using rapidly dissolving poly‐ [37] BARAKAT M R，WYKOFF C C，GONZALEZ V，et al.
meric microneedles[J]. Drug Deliv Transl Res，2018，8 Suprachoroidal CLS-TA plus intravitreal aflibercept for
（3）：473-483. diabetic macular edema：a randomized，double-masked，
[25] CUI M Y，ZHENG M J，WIRAJA C，et al. Ocular deli- parallel-design，controlled study[J]. Ophthalmol Retina，
very of predatory bacteria with cryo-microneedles against 2021，5（1）：60-70.
eye infection[J]. Adv Sci （Weinh），2021，8（21）： [38] NAWAR A E. Effectiveness of suprachoroidal injection of
e2102327. triamcinolone acetonide in resistant diabetic macular
[26] FANG Y R，ZHUO L，YUAN H，et al. Construction of edema using a modified microneedle[J]. Clin Ophthalmol，
graphene quantum dot-based dissolving microneedle 2022，16：3821-3831.
patches for the treatment of bacterial keratitis[J]. Int J [39] MUYA L，KANSARA V，CAVET M E，et al. Suprachoroi‐
Pharm，2023，639：122945. dal injection of triamcinolone acetonide suspension：ocu‐
[27] JIANG X，JIN Y L，ZENG Y N，et al. Self-implantable lar pharmacokinetics and distribution in rabbits demon‐
core-shell microneedle patch for long-acting treatment of strate high and durable levels in the chorioretina[J]. J Ocul
keratitis via programmed drug release[J]. Small，2024，20 Pharmacol Ther，2022，38（6）：459-467.
（29）：e2310461. [40] YEH S，KHURANA R N，SHAH M，et al. Efficacy and
[28] MAHFUFAH U，SYA’BAN MAHFUD M A，SAPUTRA safety of suprachoroidal CLS-TA for macular edema
M D，et al. Incorporation of inclusion complexes in the secondary to noninfectious uveitis：phase 3 randomized
dissolvable microneedle ocular patch system for the effi‐ trial[J]. Ophthalmology，2020，127（7）：948-955.
ciency of fluconazole in the therapy of fungal keratitis[J]. [41] FITAIHI R，ABUKHAMEES S，ORLU M，et al. Trans-
ACS Appl Mater Interfaces，2024，16（20）：25637-25651. scleral delivery of dexamethasone-loaded microparticles
[29] SHI H，ZHOU J H，WANG Y，et al. A rapid corneal hea- using a dissolving microneedle array[J]. Pharmaceutics，
ling microneedle for efficient ocular drug delivery[J]. 2023，15（6）：16.
Small，2022，18（4）：e2104657. [42] ALRBYAWI H，ANNAJI M，FASINA O，et al. Rapidly
[30] ALBADR A A，TEKKO I A，VORA L K，et al. Rapidly dissolving trans-scleral microneedles for intraocular deli-
dissolving microneedle patch of amphotericin B for intra‐ very of cyclosporine A[J]. AAPS PharmSciTech，2024，
corneal fungal infections[J]. Drug Deliv Transl Res，2022， 25（2）：28.
12（4）：931-94. [43] THAN A，LIU C H，CHANG H，et al. Self-implantable
[31] YADAV K S，RAJPUROHIT R，SHARMA S. Glaucoma： double-layered micro-drug-reservoirs for efficient and
current treatment and impact of advanced drug delivery controlled ocular drug delivery[J]. Nat Commun，2018，
systems[J]. Life Sci，2019，221：362-376. 9（1）：44.
[32] YAMAGISHI-KIMURA R，HONJO M，AIHARA M. Ef‐ [44] SAVINAINEN A，GROSSNIKLAUS H，KANG S，et al.
fect of a fixed combination of ripasudil and brimonidine Ocular distribution and efficacy after suprachoroidal injec‐
on aqueous humor dynamics in mice[J]. Sci Rep，2024，14 tion of AU-011 for treatment of ocular melanoma[J]. In‐
（1）：7861. vest Ophth Vis Sci，2020，61：3615.
[33] DING K，SHEN J K，HAFIZ Z，et al. AAV8-vectored su‐ （收稿日期：2024-07-18 修回日期：2024-12-25）
prachoroidal gene transfer produces widespread ocular （编辑：胡晓霖）
transgene expression[J]. J Clin Invest，2019，129（11）：

· 372 · China Pharmacy 2025 Vol. 36 No. 3 中国药房 2025年第36卷第3期